China's top drug regulator said on Monday that it has granted conditional approval for a homegrown oral pill to be used to treat COVID-19 disease, adding to the growing medical arsenal against the novel coronavirus.
China released its first diagnosis and treatment guideline for monkeypox on June 15, making it clear that the virus can spread through close contact and droplets, but most patients can recover without special treatment.
Scientists stressed the need to inoculate the vulnerable while urging vigilance against the newly discovered Omicron subvariants, and called for more research to understand their quick transmissibility and severity.
Positive progress has been made in the development of monovalent and multivalent vaccines against the Omicron variants, a senior Chinese health official told a press conference on Saturday.
Modifications to China's COVID-19 diagnosis and treatment guidelines are aimed at relieving strains on the medical system in the face of the highly contagious Omicron variant, officials and experts said.
Fully vaccinated people in China can now choose to receive a different shot from their original inoculation as a booster in a process called sequential immunization.
Nearly two years after the COVID-19 outbreak, China has granted emergency approval for its first antibody combination therapy for COVID-19 treatment, adding a tool to the world's arsenal against the disease.
Answers to commonly-asked questions about the Omicron variant of COVID-19.